This course has expired. View available courses.
Expired
Acute Lymphoblastic Leukaemia in Adults
This module presented by Dr Shaun Fleming, provides an overview of the current guideline treatments for adult Acute Lymphoblastic Leukaemia, as well as recognising the roles of targeted therapies and immunotherapies, and patient risks to guide treatment decisions for patients with ALL.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2021-03-31
This module presented by Dr Shaun Fleming, provides an overview of the current guideline treatments for adult Acute Lymphoblastic Leukaemia, as well as recognising the roles of targeted therapies and immunotherapies, and patient risks to guide treatment decisions for patients with ALL.
Faculty
Dr Shaun Fleming
MBBS (Hons), FRACP, FRCPA
Clinical and Laboratory Haematologist
Alfred Health & Northern Health, Melbourne, VIC
Learning objectives
At the end of this module, you will be better able to:
- Describe the current guideline-recommended treatment regimens for adult ALL, including paediatric-inspired regimens, and their survival outcomes
- Recognise the varying roles of current targeted therapies and immunotherapies in different subtypes of adult ALL
- Identify the factors associated with prognostication in adult ALL
- Explain how measurable residual disease and new genomic risk grouping helps to classify patient risk and guide treatment decisions in ALL